Mercy Hospital, located in Coon Rapids, Minnesota, is a 471-bed non-profit hospital that serves the northern Twin Cities metropolitan area. Mercy Hospital is part of Allina Health. Mercy offers specialty services including behavioral health, cancer care, heart and vascular services, orthopedics and neuroscience.

There are 471 beds in Mercy Hospital.

During the past decade, Mercy Hospital conducted 205 clinical trials. In the 10-year time frame, 205 clinical trials started and 161 clinical trials were completed, i.e. on average, 78.5% percent of trials that started reached the finish line to date. In the past 5 years, 90 clinical trials started and 92 clinical trials were completed. i.e. 102.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 169 trials, followed by "Alliance for Clinical Trials in Oncology" with 46 trials sponsored, "SWOG Cancer Research Network" with 43 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 164 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 7 trials as a collaborator. Other collaborators include 60 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital" are "Recurrent Ovarian Carcinoma" (14 trials), "Recurrent Breast Carcinoma" (12 trials), "Ovarian Seromucinous Carcinoma" (11 trials), "Coronary Artery Disease" (10 trials) and "Invasive Breast Carcinoma" (10 trials). Many other conditions were trialed in "Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Hospital" are "Drug" (274 trials), "Other" (215 trials), "Biological" (131 trials), "Procedure" (87 trials) and "Radiation" (54 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (109 trials), "Quality-of-Life Assessment" (95 trials), "Questionnaire Administration" (55 trials), "Paclitaxel" (48 trials) and "Carboplatin" (39 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital" are 283 trials for "All" genders, 64 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Hospital". undefined are not yet recruiting, 76 are recruiting, 146 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 107 completed trials in Mercy Hospital, 7 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital, 10 "Phase 1" clinical trials were conducted, 164 "Phase 2" clinical trials and 166 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 20 trials that are defined as “Not Applicable".

Mercy Hospital has several departments that took part in Clinical trials: "Minneapolis Heart Institute" - 101 trials, "Division of Vascular Surgery - Minneapolis Heart Institute" - 2 trials